What is cholecystitis, including its definition, causes, clinical presentation, and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is Cholecystitis?

Cholecystitis is an acute inflammation of the gallbladder, most commonly (90-95% of cases) caused by gallstone obstruction of the cystic duct, affecting approximately 200,000 people annually in the United States 1.

Definition and Pathophysiology

Acute cholecystitis (AC) represents a life-threatening emergency that occurs when the gallbladder becomes inflamed 2. While cystic duct obstruction from gallstones is the predominant mechanism, the pathogenesis involves more than just mechanical obstruction alone 3.

Acalculous cholecystitis accounts for 5-10% of cases and occurs without gallstones, typically in critically ill patients 1.

Clinical Presentation

The classic presentation includes:

  • Right upper quadrant pain (often acute onset, may be associated with eating)
  • Fever
  • Nausea and vomiting
  • Murphy's sign (right upper quadrant tenderness with inspiratory arrest during palpation)
  • Elevated white blood cell count

1, 2

Important Caveat

Not all patients present with classic findings 3. Acute cholecystitis can occur without leukocytosis, fever, or positive Murphy's sign, requiring a high index of suspicion and thorough diagnostic workup 3.

Diagnostic Approach

Initial Imaging

  • Right upper quadrant ultrasonography is the first-line test (sensitivity ~81%, specificity ~83%) 1
  • Look for: gallstones, gallbladder wall thickening, pericholecystic fluid, sonographic Murphy's sign

When Ultrasound is Equivocal

  • Hepatobiliary scintigraphy (HIDA scan) is the gold standard diagnostic test when ultrasound findings are inconclusive 1, 3
  • CT and MRI are useful for identifying complications 2

Management Strategy

First-Line Treatment: Early Laparoscopic Cholecystectomy

Early laparoscopic cholecystectomy (ELC) performed within 1-3 days of diagnosis is superior to delayed surgery and should be the first-choice treatment for most patients, including high-risk individuals 4, 1.

The evidence strongly supports this approach:

  • Fewer postoperative complications (11.8% early vs 34.4% late) 1
  • Shorter hospital stay (5.4 vs 10.0 days) 1
  • Lower hospital costs 1
  • Optimal timeframe: within 72 hours of diagnosis, with possible extension to 7-10 days from symptom onset 5

Medical Management Before Surgery

While awaiting ELC, provide:

  • Fasting
  • Intravenous fluid resuscitation
  • Antimicrobial therapy (see below)
  • Analgesics as needed

5

Antibiotic Selection

For uncomplicated cholecystitis: First-line antibiotics include cefazolin, ceftriaxone, or cefuroxime per IDSA guidelines 6

For complicated cholecystitis in elderly or high-risk patients: Broad-spectrum regimens are necessary, considering local resistance patterns and the most frequently isolated organisms (E. coli, Klebsiella, Bacteroides fragilis) 7

Critical point: Postoperative antibiotics are NOT needed when the infection source is controlled by cholecystectomy in uncomplicated cases 7. Studies show no difference in postoperative infection rates between antibiotic continuation (15%) versus no antibiotics (17%) after surgery 7.

High-Risk Patients

Immediate laparoscopic cholecystectomy is superior to percutaneous transhepatic gallbladder drainage (PTGBD) even in high-risk patients 4. The landmark CHOCOLATE trial demonstrated:

  • 5% complications with ELC vs 53% with PTGBD 4
  • Significantly fewer recurrent biliary events with surgery 4
  • Similar mortality rates between groups 4

When Surgery Must Be Delayed or Avoided

For patients truly unfit for surgery:

  • Percutaneous cholecystostomy can serve as bridge therapy or definitive treatment 1, 2
  • However, be aware that percutaneous drainage has higher complication rates (65%) compared to laparoscopic cholecystectomy (12%) 1
  • If surgery is delayed, wait at least 6 weeks after clinical presentation 5

Special Populations

Pregnant women: Early laparoscopic cholecystectomy is recommended during all trimesters, with lower maternal-fetal complications (1.6% early vs 18.4% delayed) 1

Elderly patients (>65 years): Laparoscopic cholecystectomy shows lower 2-year mortality (15.2%) compared to nonoperative management (29.3%) 1. However, guidelines are frequently not followed in healthy octogenarians, who could benefit from surgery 8.

Common Pitfalls

  • Assuming all high-risk patients need drainage instead of surgery - The evidence now strongly supports ELC even in critically ill patients 4
  • Continuing antibiotics postoperatively in uncomplicated cases - This provides no benefit 7
  • Delaying surgery beyond 72 hours without clear contraindication - This increases complications and costs 1
  • Missing the diagnosis when classic signs are absent - Maintain high suspicion even without fever, leukocytosis, or positive Murphy's sign 3

References

2
Research

Clinical Presentation, Imaging, and Management of Acute Cholecystitis.

Techniques in vascular and interventional radiology, 2015

Related Questions

What are the signs and symptoms of acute cholecystitis?
What is acute cholecystitis, including its definition, classification, clinical features, investigations, pathogenesis, pathology, and surgical treatment?
What is the recommended medical management for acute cholecystitis?
What are the differential diagnoses for a patient presenting with symptoms of acute cholecystitis, likely caused by gallstones, and experiencing right upper quadrant abdominal pain, fever, and leukocytosis?
What are the risk factors and etiologic causes of acute cholecystitis?
Can albumin 12.5 g in 250 mL (total 25 g in 500 mL) be infused over 4 hours, or should the infusion be administered more slowly?
How should atorvastatin (10 mg daily) be co‑administered with fenofibrate (145 mg with meals) and what monitoring is required for a patient needing both LDL‑cholesterol and triglyceride reduction, assuming normal liver function, CK levels, no severe hepatic or muscle disease, and adequate renal function?
If I am unable to calculate creatinine clearance, what practical anticoagulation strategy should I use for this patient?
In an elderly female patient with dementia, can renal function be estimated using only serum creatinine, or is creatinine clearance required?
How should a patient with a positive rectal swab screening for multidrug-resistant Escherichia coli be managed?
What tests are used to evaluate pancreatic structure and function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.